Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00109135
Status:
COMPLETED
Last Update Posted:
2015-09-25
First Post:
2005-04-22
Brief Title:
A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers 0364-007
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Double-Blind Multicenter Randomized Titrated-Dose Placebo-Controlled Study of MK0364 4 mg to 8 mg in Chronic Cigarette Smokers as an Aid for Smoking Cessation
Status:
COMPLETED
Status Verified Date:
2015-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and tolerability of an investigational drug that may help individuals to stop smoking
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MK-0364-007 | None | None | None |
| 2005_012 | None | None | None |